Purpose: To evaluate the effectiveness of neuroprotective therapy in patients with primary open-angle glaucoma based on specific biochemical markers of neurotrophy and neurodegeneration.
Material And Methods: In the course of the study, lacrimal fluid (LF) of 23 patients (46 eyes) with stage I-II primary open angle glaucoma (POAG) aged 66.3±10.
The paper gives the comparative results of infrared exposure, drug and multimodality treatment in partial optic nerve atrophy of varying degrees, as evidenced by Doppler, electrophysiological, and morphometric studies.
View Article and Find Full Text PDF